AUPH vs TT · P/E 28, rev $283.1M vs P/E 36, rev $21.32B
Aurinia Pharmaceuticals Inc (AUPH) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the AUPH and TT stock pages for the full models.
Not investment advice.